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Abstract
Both DSM-5 and ICD-11 have provided weight cut-offs and severity specifiers for the diagnosis of anorexia nervosa (AN) in 
childhood, adolescence and adulthood. The aims of the current study focusing on inpatients aged < 19 years were to assess (1) 
the relationship between age and body mass index (BMI; kg/m2), BMI-centiles, BMI-standard deviation scores (BMI-SDS) 
and body height-SDS at referral, (2) the percentages of patients fulfilling the DSM-5 and ICD-11 weight criteria and severity 
categories for AN, and (3) the validity of the AN severity specifiers via analysis of both weight related data at discharge and 
inpatient treatment duration. The German Registry for Anorexia Nervosa encompassed complete data sets for 469 female 
patients (mean age = 15.2 years; range 8.9–18.9 years) with a diagnosis of AN (n = 404) or atypical AN (n = 65), who were 
ascertained at 16 German child and adolescent psychiatric hospitals. BMI at referral increased up to age 15 to subsequently 
plateau. Approximately one tenth of all patients with AN had a BMI above the fifth centile. The ICD-11 specifier based on a 
BMI-centile of 0.3 for childhood and adolescent AN entailed two equally sized groups of patients. Discharge data revealed 
limited validity of the specifiers. Height-SDS was not correlated with age thus stunting had no impact on our data. We cor-
roborate the evidence to use the tenth instead of the fifth BMI-centile as the weight criterion in children and adolescents. 
Weight criteria should not entail major diagnostic shifts during the transition from adolescence to adulthood. The severity 
specifiers based on BMI or BMI-centiles do not seem to have substantial clinical validity.
Keywords BMI-centile · BMI-SDS · Weight criterion · Early onset anorexia nervosa · Atypical anorexia nervosa
Introduction
Underweight, fear of weight gain, and body image dis-
turbances represent cardinal features of anorexia nervosa 
(AN) [1]. The definition of the underweight associated with 
AN has been subject to change. Thus, DSM-5 rephrased 
the DSM-IV TR weight criterion for AN to “a significantly 
low body weight in the context of age, sex, developmental 
trajectory, and physical health” [1]. Whereas no cut-off is 
provided in the A criterion, the main text specifically states 
that the body mass index (BMI; kg/m2) is a “useful measure 
to assess body weight for height” [1]. Based on the defini-
tion of underweight according to both the Centers for Dis-
ease Control and Prevention (CDC) and the World Health 
Organization (WHO) a BMI ≤ 18.5 kg/m2 was provided as 
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a guideline for adults [1]. However, a BMI above 18.5 kg/
m2 “might be considered to have significantly low weight if 
clinical history or other physiological information supports 
this judgement” [1]. For childhood and adolescent patients, 
DSM-5 refers to the CDC definition of underweight based 
on a “BMI-for-age below the fifth centile” [1]. The main 
text cautiously states that clinicians need to consider “avail-
able numerical guidelines, as well as the individual’s body 
build, weight history, and any physiological disturbance” [1] 
in judging the weight of a young patient; somewhat higher 
cut-offs may be appropriate for individual patients. Over-
all, BMI-centiles were introduced to allow comparability 
of body weight adjusted for height across childhood and 
adolescence in light of the age dependency of absolute BMI-
values; Hebebrand and coworkers had initially suggested 
replacement of the DSM-IV weight criterion (body weight 
less than 85% of that expected) with the 10th BMI-centile 
in 1996 [2].
The more recent ICD-11 [3] weight criterion is shorter 
and provides a strict cut-off. Specifically, “AN is character-
ized by significantly low body weight for the individual’s 
height, age and developmental stage” [3]; the diagnosis is 
dependent on a “BMI less than 18.5 kg/m2 in adults and 
BMI-for-age under fifth percentile in children and adoles-
cents that is not due to another health condition or the una-
vailability of food” [3].
Both classification systems introduced different BMI-
specifiers to grade the underweight of patients diagnosed 
with AN. In DSM-5 the subcategorizations for mild, moder-
ate, severe and extreme AN are based on absolute BMI of 
(i) ≥ 17, (ii) 16–16.99, (iii) 15–15.99 and (iv) < 15 kg/m2. 
For children and adolescents, the corresponding BMI-cen-
tiles are to be used (not specifically delineated in the main 
text). DSM-5 allows for an increase in the level of sever-
ity “to reflect clinical symptoms, the degree of functional 
disability, and the need for supervision” [1]. The ICD-11 
subcategorization merely separates adult patients according 
to BMI ≥ 14 or < 14 kg/m2 to define AN with significantly 
and dangerously low body weight, respectively. For children 
and adolescents, ICD-11 refers to a BMI below the fifth 
centile and ≥ 0.3rd centile and a BMI < 0.3rd centile for the 
specification in these two subcategories [3].
Further research is warranted to describe the BMI-dis-
tribution of patients < 18 years in relationship to age. We 
are aware of a single study that has previously classified 
young patients with AN and atypical AN upon initial refer-
ral to a Danish university eating disorders unit according to 
low (< 5th centile), medium (5th to 10th centile) and high 
(≥ 10th centile) BMI-centile groups [4]. The investigators 
questioned the applicability of the fifth BMI-centile as a sub-
stantiated cut-off for the weight criterion in youths with AN 
due to the fact that 12% and 15% of patients diagnosed as 
having AN belonged to the medium and high BMI-groups.
The use of the fifth BMI-centile as the weight cut-off had 
previously been deemed too strict in that it would prevent 
a larger group of patients from receiving the diagnosis of 
AN [5, 6]. In addition, the DSM-IV weight cut-off (“body 
weight less than 85% of that expected”) had been shown 
to correspond to absolute BMI-values that age dependently 
fall between the fifth and tenth BMI-centile [2], leading the 
investigators to favor the use of the tenth BMI-centile as the 
more inclusive weight cut-off.
The aims of the current study were to descriptively assess 
the distributions of absolute BMI, BMI-centiles, and BMI-
standard deviation scores (BMI-SDS) of young patients 
requiring inpatient treatment in relationship to age to sub-
sequently assess the DSM-5 and ICD-11 weight criteria and 
severity specifiers for childhood and adolescent AN. We also 
compare our results to internationally available studies on 
DMS-5 severity specifiers. Because starvation induced stunt-
ing may affect patients with a younger age at onset more 
strongly than those with an older age at onset [7, 8], we addi-
tionally assessed body height-SDS in relationship to age. 
In light of largely lacking data on the clinical implications 
of a severity grading based on body weight at referral, we 
assessed the relationship between different severity staging 
criteria and mean length of inpatient treatment and BMI and 
BMI-SDS at discharge, respectively. We specifically hypoth-
esized that a subgroup of the inpatients diagnosed as having 
AN has a BMI above the fifth centile.
Materials and methods
Data of patients of the multi-center German Registry of 
Children and Adolescents with AN [9–11] were used for 
the current analyses. Enrolled inpatients were admitted to 
the 16 participating child and adolescent psychiatric hos-
pitals [10, 11] between August 2014 and February 2019. 
The ethics committees of all centers approved the registry 
study. Only complete records of patients including sex, age, 
date of referral, date of discharge, weight, height (both at 
referral and discharge) and diagnosis of DSM-5 AN (includ-
ing subtype) or atypical AN within the umbrella diagnosis 
‘Other Specified Feeding or Eating Disorder’ were included 
in the study. DSM-5 diagnoses were clinical diagnoses by 
the clinician in charge at each of the local centers. DSM-5 
criteria were provided in the registry data entry to increase 
reliability of the diagnoses; a BMI up to the  10th centile 
was perceived as still compatible with the DSM-5 weight 
criterion for AN. Atypical AN was diagnosed if only two 
of the three criteria for AN were met and the overall clini-
cal impression was considered as being similar to AN (this 
definition of atypical AN deviates slightly from that given 
in DSM-5 to additionally allow this diagnosis in patients 
fulfilling the A criterion and either criterion B or C).
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Apart from availability of all data outlined above, the 
following inclusion criteria were applied to the selection 
of the respective data sets: female sex (exclusion of 21 
males), age < 19 years at referral and written informed con-
sent (patient and legal guardians). Treatment duration was 
calculated as the difference between dates of discharge and 
referral (for data protection reasons only months and years 
were available).
At all participating centers body weight and height were 
measured at referral and discharge using calibrated hospi-
tal scales and stadiometers. Participants were weighed in 
underwear without shoes. BMI was calculated by divid-
ing weight by the square of height (kg/m2). On the basis of 
nationally representative German reference data for children 
(KiGGS) [12], individual BMI-values were transformed into 
BMI-SDS and BMI-centiles using the method suggested by 
Cole [13]. The method was adapted for the calculation of 
BMI-SDS by Kromeyer-Hausschild et al. (2001) [14]. The 
calculation followed the formula:  SDSLMS = ([BMI/M(t)]L(t) 
− 1)/(L(t)S(t)), with following abbreviations: L: Box-cox-
power-transformation; M: median; S: variation coefficient; 
BMI: individual BMI [14]. The BMI-SDS approximates the 
deviation of an individual BMI from the median of the ref-
erence group expressed in units of the standard deviation.
In ten patients with a BMI ≥ 10th centile, the clinician 
based diagnosis of AN, restricting type, was converted to 
atypical anorexia (see discussion). We determined the BMI-
SDS corresponding to the ICD-11 specifier (0.3rd centile) 
using the German reference data [12]. Using the same 
method [13] and reference data [12], we also transformed 
individual body heights into height-SDS to investigate 
potential age dependent effects of starvation induced stunt-
ing on body height.
We applied local regression („loess “) to fit smooth curves 
to some of our scatterplot data with Epanechnikov–Kerner-
function using 50% points to fit [15]. The procedure is a 
fairly direct generalization of traditional least-squares meth-
ods for data analysis. The procedure is nonparametric in the 
sense that the fitting technique does not require an a priori 
specification of the relationship between the dependent and 
independent variables. Data analysis with loess allows the 
exploration of bivariate and multivariate data, assessment of 
functional forms for relationships among variables, examina-
tion of model assumptions in regression analysis, and rep-
resentation of complex structures within data. The major 
weakness of loess like of all nonparametric fitting methods 
is that it cannot be used to characterize the data in terms of 
a simple equation. The second limitation is that this method 
requires the analyst to make several partially arbitrary deci-
sions about the fitting parameters [15].
Descriptive data are presented as means, standard 
deviations, 90% confidence intervals of means (computed 
using standard error and z-score), ranges, and  5th and  95th 
percentile. Spearman’s correlations were calculated to assess 
associations between age and BMI. The confidence intervals 
for correlation coefficients were computed by the bias cor-
rected and accelerated bootstrap method (BCa 95% CI) [16]. 
We tested the effect of potential covariates such as centre 
(linear mixed model), year of admission (ANCOVA) and 
disease duration (linear regression model) on associations 
between age and BMI or BMI-SDS.
To compare the patients at time of discharge (T1) in 
relationship to the ICD-11 severity specifier (0.3rd BMI-
centile), we performed the Mann–Whitney test.
Exact two-sided significances were calculated, the alpha 
level was set to 0.05. We performed two separate corrections 
of P values for multiple testing according to Bonferroni: (1) 
for 21 correlations (according to our original analysis plan, 
21 tests were conducted, of which 7 were not presented in 
the final manuscript) between age at referral (T0) and BMI 
and BMI-SDS of inpatients with AN or atypical AN (see 
Table 2), (2) for three tests to assess the ICD-11 specifier for 
data at discharge (see Table 4). All analyses were performed 
using  IBM®  SPSS® Statistics 25.0.0.1 for Windows. The 
plots for the Supplementary information were created with 
R (R Core Team (2018), a language and environment for 
statistical computing. R Foundation for Statistical Comput-
ing, Vienna, Austria, https ://www.R-proje ct.org/).
Results
Descriptive data and the distribution of variables in patient 
groups diagnosed with AN or atypical AN according to 
DSM-5 are shown in Table 1 and Fig. S1–S3.
Relationship between age and BMI and BMI‑SDS
The mean age of the 469 patients (AN + atypical AN) was 
15.17 (SD = 1.64; range 8.92–18.92) years. At the descrip-
tive level BMI at referral increased to age 15 to subsequently 
plateau up to age 18 (Fig. 1), which represented the old-
est age for study inclusion. Correlations between BMI and 
age (Table 2) confirmed the visual impression: Only BMI 
of patients < 15 years (n = 200; 42.6% of all patients) mod-
erately increased with age (r ≈ 0.5); in contrast, the sub-
analysis of patients aged ≥ 15.0 years revealed a correlation 
close to zero. Based on our cross-sectional data, correlations 
within age defined subgroups including the 95% confidence 
intervals (CI) between BMI and age were highest in the 
youngest age group of the 404 patients with AN; as of age 
15 the 95% CI included zero (Fig. 2).
In contrast to absolute BMI, BMI-SDS was negatively 
correlated with age at referral for inpatient treatment 
(Table 2; Fig. 3), i.e., older patients at referral tended to 
have a BMI more deviant from the normal range of their 
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age group than younger patients. The negative correlation 
was only accounted for by patients aged 15 or older. The 
analyses pertaining to the potential covariates revealed no 
significant effect of center, year of admission or duration 
of the eating disorder (data not shown; for descriptive data 
see Figs. S4–S7, Tables S1 and S2).
The transformation of BMI-SDS into BMI-centiles 
eliminated a substantial part of the variance in this 
Fig. 1  Scatterplot for age and BMI at referral (T0) of 469 inpatients 
with Anorexia Nervosa (AN; differentiated according to restricting or 
binge eating/purging type) or atypical AN including local regression 
(loess) in relationship to the ICD-11 specifier of BMI ≥ 14 or < 14 kg/
m2 (straight line)
Table 2  Correlations between age at referral (T0) and BMI and BMI-SDS of inpatients with Anorexia Nervosa (AN) or atypical AN
r correlation coefficient (Spearman’s rho), p P value, CI: 95% confidence intervals computed by bias corrected and accelerated bootstrap 
method, y years
*Significant after Bonferroni correction (P < 2.38 × 10–3)
All (n = 469) AN (n = 404) Atypical AN (n = 65) AN < 15 years 
(n = 171)
Atypical 
AN < 15 years 
(n = 29)
AN ≥ 15 years 
(n = 233)
Atypical 
AN ≥ 15 years 
(n = 36)
BMI kg/m2
r 0.28* 0.32* 0.24 0.47* 0.54 0.03 0.09
P 5.2 × 10–13 3.5 × 10–11 0.058 1.19 × 10–10 0.003 0.618 0.597
CI [0.19, 0.37] [0.23, 0.41] [− 0.02, .46] [0.33, 0.59] [0.23, 0.77] [− 0.11, 0.18] [− 0.29, 0.43]
BMI-SDS
r − 0.30* − 0.31* − 0.21 0.02 0.28 − 0.26* − 0.06
P 2.3 × 10–11 1.15 × 10–10 0.099 0.842 0.146 4.9 × 10–5 0.714
CI [− 0.39, − 0.21] [− 0.39, − 0.22] [− 0.44, 0.04] [− 0.15, 0.18] [− 0.12, 0.64] [− 0.39, − 0.13] [− 0.42, 0.28]
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Fig. 2  Age dependency of 
mean correlations (Spearman’s) 
and 95% confidence intervals 
between age and BMI at referral 
(T0) of 404 inpatients with 
Anorexia Nervosa for four age 
groups. Correlation coefficients 
were calculated on a cross-sec-
tional basis per age group
Fig. 3  Scatterplot for age and BMI-SDS at referral (T0) of 469 
inpatients with Anorexia Nervosa (AN; differentiated according to 
restricting or binge eating/purging type) or atypical AN including 
local regression in relationship to the ICD-11 specifier of BMI-cen-
tile ≥ 0.3 or < 0.3, which corresponded to BMI-SDS across the age 
range that skewed between 3.40 and 3.48
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specific patient group (Figs. S1c, S3c). Thus, 81 patients 
had a BMI < 0.01 centile (corresponding to a BMI-
SDS < – 3.9), entailing a clustering at the centile of zero.
We found no relationship between age at referral and 
height-SDS (Fig. 4).
Weight criterion
Of the 404 patients with AN (restricting type n = 376 and 
binge eating/purging type n = 28) n = 361 (89.4%) had a 
BMI < 5th centile (Table 3).
Severity specifiers
One-half of the 404 patients with AN fulfilled the childhood 
and adolescent ICD-11 specifications for significantly (BMI-
centile ≥ 0.3) and dangerously (BMI-centile < 0.3) low body 
weight, respectively (Table 4). Compared to patients with 
significantly low BMI, those with dangerously low BMI had 
a 2-week longer mean treatment duration (Mann–Whitney 
U = 17,128.5; P = 0.005), 0.46 kg/m2 lower BMI at discharge 
(U = 16,992.5; P = 0.004) and 0.44 lower BMI-SDS at dis-
charge (U = 13,942.5; P = 3.7 × 10–8). All three P values 
were lower than the Bonferroni corrected p value of 0.017.
Because BMI revealed no age dependency in adolescents 
aged 15–18 (Fig. 1, Table 2), we descriptively assessed both 
Fig. 4  Scatterplot for age and body height-SDS of 469 inpatients with Anorexia Nervosa including local regression (loess). Linear correlation 
r = 0.009, P = 0.844
Table 3  Numbers and percentages of inpatients fulfilling the recommended DSM-5 and absolute ICD-11 weight criterion for Anorexia Nervosa 
(AN) based on the fifth BMI-centile
BMI-centile All patients (n = 469) AN restricting type 
(n = 376)
AN binge-eating/purging type 
(n = 28)
Atypical AN (n = 65)
 < 5 395 (84.2%) 334 (88.8%) 27 (96.4%) 34 (52.3%)
 ≥ 5 74 (15.8%) 42 (11. 2%) 1 (3.6%) 31 (47.7%)
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the DSM-5 and ICD-11 adult severity specifiers based on 
absolute BMI-cut-offs (Table 5 and Table 6) and used inpa-
tient treatment duration and both BMI and BMI-SDS at 
discharge as proxies to assess the clinical validity of the 
different severity categories.
Discussion
Both BMI and BMI-SDS at referral are clearly age depend-
ent in young inpatients with acute AN, with the correlations 
being positive for BMI and negative for BMI-SDS. With 
respect to absolute BMI, females aged < 15 years as a group 
tended to have lower referral BMI than patients ≥ 15 years 
old. Our sample included 34 patients aged < 12 years, for 
whom we found the highest correlation (r ≈ 0.5; Fig. 2) 
between age and BMI; this correlation drops in the next 
oldest age groups to approach zero as of age 15 (Table 2). It 
deserves mentioning that the absolute BMI-values constitut-
ing the fifth or tenth BMI-centile according to both the US 
CDC [17] and German KiGGS [12] reference data do not 
plateau, thus excluding the possibility that the observed pla-
teau in inpatients with AN is related to a general cessation of 
increments in BMI in the underweight range between ages 
15 and 18.
It is of obvious interest to determine if the plateau 
observed between age 15 and 18 persists into adulthood (in 
particular during the age span during which AN manifests) 
or if further age dependent increments occur after age 18. 
If the plateau indeed extends beyond age 18, both weight 
cut-offs for the diagnosis of AN and absolute BMI-severity 
specifiers could apply as of age 15, thus allowing the use 
of the same cut-offs/specifiers in adults and adolescents 
aged ≥ 15 years. Because, in younger patients, BMI-SDS 
shows no correlation to age (Table 2), a specific BMI-SDS 
or BMI-centile (e.g., 10th BMI-centile; see below) could be 
used as the weight criterion.
The drop in correlations between BMI and age (Fig. 2) 
presumably reflects the increasing number of female patients 
who completed puberty. Thus, in a longitudinal study includ-
ing 615 white females recruited at age 9 (77.2% pre-puber-
tal) and followed-up for 10 years the mean onset of puberty 
was 10.2 years, being 12.6 years for the onset of menarche 
and 14.3 years for entering Tanner growth stage 5 [18]. Full 
adult height was achieved at 17.1 years. The correlations 
between age and BMI at referral dropped across the time 
Table 4  Inpatients with Anorexia Nervosa fulfilling the ICD-11 specifications of significantly low and dangerously low body weight at referral 
(T0) in relationship to mean inpatient treatment duration and BMI and BMI-SDS at discharge (T1)
ICD-11 BMI-centile n Mean treatment duration in weeks 
(± SD)
BMI T1 mean (± SD) BMI-SDS T1 
mean (± SD)
 ≤ 0.3 202 18.78 (8.43) 18.08 (1.54) − 1.36 (0.88)
 > 0.3 202 16.85 (8.97) 18.54 (1.22) − 0.93 (0.52)
Table 5  DSM-5 severity specifiers based on absolute BMI-values at referral (T0) according to DSM-5 in patients with Anorexia Nervosa (AN) 
aged ≥ 15 years and relationship with BMI, BMI-SDS at discharge (T1) and treatment duration
BMI T0 AN (n = 233) BMI T1 mean (SD) BMI-SDS T1 mean (SD) Treatment 
duration 
(weeks)
 < 15 kg/m2 81 (34.76%) 18.17 (1.47) − 1.59 (1.03) 20.57 (9.57)
15–15.99 kg/m2 66 (28.33%) 18.74 (1.41) − 1.20 (0.79) 16.94 (7.39)
16–16.99 kg/m2 57 (24.46%) 18.93 (1.09) − 1.09 (0.55) 16.32 (8.66)
 ≥ 17 kg/m2 29 (12.45%) 19.34 (0.92) − 0.91 (0.42) 11.27 (5.53)
Table 6  ICD-11 adult specifiers for significantly low and dangerously 
low body weight based on a BMI < or ≥ 14  kg/m2 at referral (T0), 
respective absolute BMI and BMI-SDS at referral for inpatient treat-
ment in 233 patients with Anorexia Nervosa aged ≥ 15 years and rela-
tionship with BMI, BMI-SDS at discharge (T1) and with treatment 
duration
BMI at referral N BMI T0 mean (SD) BMI-SDS T0 mean (SD) BMI T1 mean (SD) BMI-SDS T1 mean (SD) Treatment 
duration mean 
(SD)
 < 14 kg/m2 23 (9.9%) 13.41 (0.45) − 5.66 (0.99) 17.88 (1.91) − 1.93 (1.48) 21.93 (11.51)
 ≥ 14 kg/m2 210 (90.1%) 15.79 (1.07) − 2.98 (0.87) 18.75 (1.26) − 1.20 (0.70) 16.84 (8.32)
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span during which puberty and also the relative increase in 
fat mass occurs.
We hypothesize that the negative correlation between 
age and BMI-SDS reflects the increasing fat mass and % 
body fat (total fat mass divided by total body mass × 100; 
%BF) in females during puberty. During puberty, % body 
fat increases by approximately 50% in females [19]. As 
such, older females may be able to lose more weight due 
to a higher fat mass before fat free mass is affected to such 
a degree that health is seriously compromised. Thus, lower 
BMI-SDS may be achieved in older individuals. Indeed, the 
comparison of body composition prior to and after weight 
gain in 130 patients with AN with a mean age of 20 years 
revealed a stronger increment in mean fat mass (6.6 kg) than 
in mean fat-free mass (5.2 kg) [20].
Starvation induced stunting should preferentially affect 
those patients who have not achieved their final height. 
Stunting should entail disproportionately higher BMI in 
younger patients due to the effect of a reduced squared 
height in meters as the denominator of the index. However, 
we observed the opposite: we found lower BMI in young 
patients as compared to those aged > 15 years. Further, 
height-SDS showed no relationship to age (Fig. 4). Ano-
rexia nervosa seemingly does not affect growth to an extent 
that would allow its detection in our large sample including 
171 patients aged < 15 years. In accordance with our results, 
two recent meta-analyses found no deviation in height at 
baseline [7, 21]. Nevertheless, stunting has repeatedly been 
reported in patients with AN [7]. Apparently, the relation-
ship between stunting and starvation is more complex and 
seemingly cannot be reduced to nutrition alone [22].
In clinical practice, BMI-centiles are used to define cut-
offs for different weight categories [1, 3]. The DSM-5 weight 
recommendations were based on CDC reference BMI data 
[1]. International comparisons of absolute BMI-values con-
stituting specific centiles in the underweight range are war-
ranted and need to be set into relationship to representative 
data sets for referral BMI of patients with AN. Because the 
absolute BMI-values constituting the  10th BMI-centile in 
both CDC and KiGGS data sets reveal slight differences 
which increase with age, the use of the  10th BMI-centile as 
weight cut-off in both the US and German population would 
entail slightly higher absolute BMI-values in the German 
data set (likely the result of different socio-economic, ethnic 
and ancestry compositions of respective populations) [12, 
17].
Irrespective of these differences, this study again under-
scores that the BMI-cut-off based on the  5th centile provided 
in both DSM-5 (main text) and ICD-11 for children and ado-
lescents is too strict entailing that a substantial proportion of 
patients with an AN-like phenotype would need to be clas-
sified as atypical AN. This situation is exactly opposite to 
one of the central aims of the DSM-5 Eating Disorders Work 
Group, namely the reduction of the percentage of eating dis-
ordered patients with a DSM-IV diagnosis of an Eating Dis-
order Not Otherwise Specified [23]. Notably, in DSM-5 the 
fifth BMI-centile is provided merely as a guideline, whereas 
in ICD-11 this cut-off is an integral part of the diagnos-
tic criteria. Accordingly, it is particularly the strict ICD-11 
weight criterion that in our opinion requires reconsideration. 
If it is to remain a diagnostic feature, we would have diag-
nosed atypical AN in 10.6% of our patients (all patients with 
a BMI between the fifth and tenth centile) despite a clinical 
symptomatology otherwise indistinguishable from AN. In a 
recent Danish study [4] 12% of the patients diagnosed (ICD-
10 criteria) as having AN had a referral BMI between the 
fifth and tenth BMI centile, another 15% out of the total of 
182 patients with AN had a BMI ≥ 10th centile. The larger 
percentage in the Danish study as compared to our own is 
in part due to our decision to not allow for the diagnosis of 
AN, if the BMI of a patient was ≥ 10th centile; it may also 
reflect the inclusion of both outpatients and inpatients (the 
setting is not specified) by Andersen et al.
ICD-11 could thus refer to a more descriptive weight 
criterion as in DSM-5. However, the disadvantage of a 
descriptive and non-fixed weight criterion is that the sub-
jective evaluation of “a significantly low body weight in the 
context of age, sex, developmental trajectory, and physical 
health” [1] renders the comparison of clinical and epide-
miological data difficult. Overall, the hesitancy to provide a 
weight cut-off in the A criterion of DSM-5 is in our opinion 
not justified. If underweight is to remain a clinical feature 
of AN, then a rather high centile at the boundary between 
the underweight and normal weight range would imply that 
the A criterion can be endorsed in most patients with an 
AN-like symptomatology. For the purpose of this study, we 
had converted all diagnoses of AN to atypical AN, if the 
BMI exceeded the tenth centile, which we considered as 
the uppermost BMI-cut-off compatible with the DSM-5 A 
criterion. This approach is obviously debatable but serves 
to illustrate the difficulties encountered upon the use of a 
vaguely defined weight criterion, which leaves room for a 
subjective interpretation by the diagnostician. Hebebrand 
and Bulik [5] have previously discussed that the weight 
criterion could be omitted all together from the diagnostic 
criteria, if it is substituted by the requirement of symptoms 
of starvation, which at an individual level would be compat-
ible with “a significantly low body weight in the context of 
age, sex, developmental trajectory, and physical health” [1].
Transition also merits consideration in that the childhood/
adolescent weight cut-off should be continuous with that 
for adults. In this context, it deserves to be pointed out that 
according to US and German data [12, 17] BMI values of 
18.19 kg/m2 and 18.95 kg/m2, respectively, correspond to 
the 10th centile in females at age 18.0. Accordingly, the use 
of the 5th centile for children and adolescents would entail 
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a considerably stricter threshold for the weight criterion 
in AN than in adults; the use of the 10th percentile would 
allow for a rather smooth transition. As delineated above, 
the DSM-5 and ICD-11 adult weight cut-off (BMI < 18.5 kg/
m2) might already be applicable as of age 15. Based on the 
CDC (KiGGS) growth charts [12, 17] a BMI of 18.5 kg/m2 
corresponds to BMI-centiles of 30 (18), 23 (13), 17 (9) and 
13 (approx.6) at ages 15.0, 16.0, 17.0 and 18.0, respectively.
Three issues are relevant with respect to the severity spec-
ifiers for AN. (1) The percentages of patients fulfilling par-
ticular specifiers requires clarification. (2) The specifiers for 
childhood/adolescent AN should in essence capture similar 
percentages of patients as in adulthood; this is particularly 
pertinent upon the transition into adulthood. (3) Finally, the 
specifiers should have clinical validity.
Percentages of patients fulfilling particular 
specifiers
Based on our large sample of inpatients with AN, we were 
able to show that the ICD-11 childhood and adolescent 
severity specifier (0.3rd BMI-centile) divided our sample 
into two equally large groups.
Specifiers and transition
Because the proportion of 15–18 year-old patients who ful-
filled the ICD-11 adult specification of a dangerously low 
body weight (BMI < 14 kg/m2) was only 9.9% (Table 6) and 
therefore substantially lower than when using the 0.3rd BMI-
centile (50%; Table 4), the two cut-offs are not compatible. 
Thus, the severity specifier for children and adolescents is 
much more lenient than for adults entailing that upon transi-
tion into adulthood the two severity specifiers do not capture 
a similar group and percentage of patients. This discordance 
obfuscates comparability of predictor research of outcomes 
in youth and in adults, and a desirable harmonization of 
severity thresholds should be attempted. Future research is 
required to assess if the adult severity specifiers can already 
be used as of age 15 (Tables 5 and 6), as our data suggest. 
As such, comparisons of the percentages of patients with 
AN, who fulfill the BMI-criteria for the severity specifiers 
is warranted. Such a comparison is currently only possible 
with respect to the DSM-5 specifiers (we are unaware of 
studies that have assessed the severity specifiers provided 
for young and adult patients in ICD-11): Among 128 adult 
patients treated at an Italian hospital 32.0%, 15.6%, 14.1% 
and 38.3% were classified as having mild, moderate, severe 
and extreme AN, respectively [24]. In a second Italian study, 
273 patients with AN were drawn from a sample of 1647 
adults of both sexes consecutively referred to and assessed 
for treatment of an eating disorder at three medium size 
specialized treatment centres/sites [25]. The percentages 
of patients assigned to each DSM-5 category were rather 
similar and ranged from 23.1% (mild) to 26.7% (severe). 
No significant differences in current age and age at onset of 
AN were observed between these categories. In a Danish 
clinical sample of 146 adult patients including six males, 
frequencies were 23.3% (mild), 24.0% (moderate), 21.9% 
(severe) and 30.8% (extreme) [26]. In a Portuguese sample 
of 201 (including 8 males) treatment-seeking patients with a 
mean age of 22.4 years (SD = 9.5; range = 11–61 years), the 
respective frequencies were 36.3%, 19.9%, 14.9% and 28.9% 
[27]; again, no significant age differences were observed 
between the four groups. Finally, among 109 adult females 
with AN, who had initially been phone screened for eligibil-
ity and who consented to participate in a research project, 
the frequencies for mild and extreme severity of AN were 
64.2% and 3.7%, respectively [28]. A look at the percentage 
of our inpatients with AN aged ≥ 15 years, who fulfill the 
extreme severity specifier according to DSM-5 (34.8%; see 
Table 5), indicates that this proportion is within the range 
of the respective percentages reported in adult patients. Our 
inpatient sample based on registry data from 16 hospitals is 
to our knowledge the largest, in which both the ICD-11 and 
DSM-5 specifiers have been investigated.
Whereas this limited amount of data indicates that there 
may be no major differences of the frequencies of the four 
severity grades between adults and adolescents aged 15–18 
and in particular in the extreme category, a systematic inter-
national approach combining clinical data from young and 
adult patients is warranted to further investigate this impor-
tant issue. A population-based approach would exclude the 
difficulties with respect to representativeness inherent to 
clinical outpatient or inpatient samples; however, the num-
ber of identified patients will be low even in large epidemio-
logical samples. Nevertheless, such data if based on a suffi-
ciently large sample might offer an orientation. We are aware 
of a single epidemiological study, in which a small number 
(n = 16; including one male) of AN patients were identified 
[29]. According to the authors the minimum level of severity 
was based on BMI (for adults; for children and adolescents 
on BMI percentiles), and may be increased to reflect clinical 
symptoms, the degree of functional disability, and the need 
for supervision” [29]. The respective BMI-centiles for the 
categorization of severity were not provided, but five, four, 
four and three patients were categorized as mild, moderate, 
severe, and extreme.
Validity of specifiers The clinical validity of the four 
DSM-5 severity categories has been questioned. Most 
[24–27, 30], but not all [29] studies have questioned the 
validity of these specifiers using different approaches 
based on age [26], eating disorder symptomatology includ-
ing binge eating, purging behavior and excessive exercise 
[24, 26–28, 30], comorbid psychopathology [28], outcome 
(weight recovery, good outcome) [24], number of previous 
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hospitalizations [30], quality of life, physical health, psycho-
social impairment, and seeking of treatment by health care 
services [29]. Collectively, these data seem to support that 
the severity criteria need to be revised or, at least, validated 
in sufficiently large and representative samples, using illness 
characteristics and outcomes that have sufficient face valid-
ity and clinical importance. This conclusion is supported 
by the results of this study. We have used our registry based 
data to assess BMI, BMI-SDS and treatment duration in 
relationship to the DSM-5 and ICD-11 severity specifiers. 
The differences between severity categories were significant, 
but not to an extent that they would in our opinion help in 
daily clinical practice to stratify risk assessment or treatment 
(Tables 5 and 6).
In children and adolescents, but maybe in adults, too, the 
interpretation of both the weight criteria and the severity 
specifiers for AN hinges on the knowledge of the relation-
ship between premorbid BMI and BMI at referral. Signifi-
cant correlations have been observed between premorbid 
BMI-centile and BMI at referral in childhood and adolescent 
patients with AN [31, 32], but we are not aware of a similar 
study in adults. It is safe to conclude that for children and 
adolescents with AN, premorbid body weight impinges on 
both the percentages of patients who have a BMI < 5th cen-
tile and who fulfill severity specifiers based on BMI.
Results of this study need to be interpreted within its 
limitations. Despite the fact that 16 centers contributed to 
the Registry we cannot reliably deduce that the data are 
fully representative of German female inpatients with AN. 
Based on those 14 centers which entered ≥ 10 patients into 
the Registry, we were unable to detect any centre effect on 
our results. Replications in independent samples are required 
to confirm the plateauing of the BMI-distribution as of age 
15; the transition into adulthood requires further investiga-
tion. Because our Registry does not include data on out-
patients, all results need to be interpreted accordingly. We 
would assume that our inpatients have a lower BMI at refer-
ral than the outpatients treated at the same centers because 
inpatients are admitted at a low weight relative to their indi-
vidual weight history. Our criticism of the use of the 5th 
BMI-centile as being too strict would likely be even more 
valid if outpatients had been analyzed in a similar manner. 
As pointed out above, a Danish study based on presumably 
both outpatients and inpatients [4] identified a larger per-
centage of patients with BMI above this centile in compari-
son to our data. Currently, we cannot state that the relation-
ship between age and BMI/BMI-SDS applies to outpatients 
(or a combined sample), too.
Another limitation pertains to the exclusion of males with 
AN, but the sample of males was too small to allow for 
meaningful analyses. However, males with AN also need to 
be studied to assess if the data obtained in females generalize 
to males too. Another limitation of our study pertains to our 
inability to assess the exact treatment duration in days due 
to data protection reasons. We refrained from determining 
BMI-centile cut-offs for children and adolescents as based 
on the provision of absolute BMI-values for the severity 
categories in DSM-5 in light of the need of more data to 
determine if the adult specifiers are indeed age independent. 
Nevertheless, despite these limitations, to our knowledge, 
this is the largest study of children and adolescents with 
AN investigating the trajectory of BMI, BMI-centiles, and 
BMI-SDS over the pediatric age range until age 18 and in 
relationship to DSM-5 severity specifiers, and the only such 
study that investigated the same question relative to ICD-
11 specifiers. As such, we consider the results relevant, as 
they suggest the potential to use BMI as of age 15 and not 
18, at least in females with AN, and as they cast consider-
able doubt on the validity of the currently conceived BMI-
centile cut-off for AN as well as on the severity criteria for 
AN in youth, introducing significantly different subgroups 
in youths vs. adults. We to our knowledge for the first time 
assessed height-SDS in relationship to age.
In conclusion, we found evidence for a plateauing of 
the BMI-distribution upon attainment of age 15 in female 
inpatients with AN, suggesting that adult cut-offs based on 
absolute BMI-values may already be used as of age 15. We 
found no evidence for stunting in younger patients with AN. 
The fifth BMI-centile is not suited as the weight criterion 
for AN, its strict application as delineated in ICD-11 would 
entail that a considerable subgroup of patients with an AN-
like phenotype is not diagnosed as having AN. Finally, the 
severity specifiers assessed via different approaches have 
not proven to be of a sufficiently convincing clinical valid-
ity; further research is required to attempt to define clini-
cally relevant variables that justify the determination of such 
severity specifiers.
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